CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $1.09M invested in Can-Fite BioPharma in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$395K
2
+$153K
3
+$148K
4
TSS
Two Sigma Securities
New York
+$134K
5
Stifel Financial
Stifel Financial
Missouri
+$30K

Top Sellers

1
-$212K
2
-$68.4K
3
-$31K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$395K
2
$197K
3
$148K
4
$134K
5
$114K
6
$30K
7
$28K
8
$26K
9
$14K
10
$4K
11
$2.72K
12
$1.32K
13
–
14
–
15
–